Sales rise 7.99% to Rs 345.51 crore
Suven Life Sciences consolidated net loss stood at Rs 33.69 crore in Q3 FY22 as compared to a net loss of Rs 24.39 crore in Q3 FY21.
Sales rise 26.59% to Rs 27.99 crore
Sales rise 6.00% to Rs 1.59 crore
Sales decline 90.28% to Rs 0.52 crore
Sales rise 33.63% to Rs 31.15 crore
Sales decline 59.17% to Rs 0.69 crore
Sales rise 171.43% to Rs 0.38 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
